<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-ijms-21-03544">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yuan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>Z.W.</given-names>
   </name>
   <name>
    <surname>Wen</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Tee</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target</article-title>
  <source>Nat. Commun.</source>
  <year>2019</year>
  <volume>10</volume>
  <fpage>120</fpage>
  <pub-id pub-id-type="doi">10.1038/s41467-018-08015-x</pub-id>
  <?supplied-pmid 30631056?>
  <pub-id pub-id-type="pmid">30631056</pub-id>
 </element-citation>
</ref>
